New diabetes screening device used in clinical trial

Share this content:
New diabetes screening device used in clinical trial
New diabetes screening device used in clinical trial

More than 400 diabetic patients have been evaluated using the RETeval® a handheld diabetic retinopathy screening device, announced LKC Technologies.

RETeval lets a healthcare provider screen a diabetic for sight-threatening DR in less than three minutes with no dilation, regardless of pupil size or the presence of cataracts.

“The medical, diabetic care and public health communities will find great value in this technology,” said LKC Technologies President James J. Datovech. "

There is also an option where RETeval can be a hand-held, flash ERG/VEP device that will run the complete five and/or six step ISCEV flash ERG protocol using skin electrodes.

LKC will be at the ARVO Annual Meeting in Orlando, FL, from May 4-7.

close

Next Article in Products